Menopause and sexuality: Key issues in premature menopause and beyond

Annals of the New York Academy of Sciences

Volumn 1205, Issue , 2010, Pages 254-261

  Graziottin, Alessandra ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

aging; menopause; premature menopause; sexual dysfunction; testosterone

Indexed keywords

AMFEBUTAMONE; ANDROGEN; BRCA1 PROTEIN; BRCA2 PROTEIN; CORTICOSTEROID; ESTRADIOL; ESTROGEN; NORETHISTERONE; TESTOSTERONE; TIBOLONE;

AGING; ANXIETY; BEHAVIOR THERAPY; BODY IMAGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; CRYOPRESERVATION; DEPRESSION; DYSGERMINOMA; DYSPAREUNIA; EARLY MENOPAUSE; ECHOGRAPHY; ENDOMETRIOSIS; ETHNICITY; FEEDBACK SYSTEM; FEMALE FERTILITY; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; FERTILIZATION IN VITRO; FRAGILE X SYNDROME; GALACTOSEMIA; GENDER IDENTITY; GENE DELETION; GENE MUTATION; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; HYSTERECTOMY; INFERTILITY; LUPUS ERYTHEMATOSUS; MASSAGE; MOSAICISM; MUSCLE HYPOTONIA; MUSCLE STRETCHING; ORGASM; ORGASM DISORDER; OVARIECTOMY; PAIN; PATHOPHYSIOLOGY; PELVIC FLOOR MUSCLE TRAINING; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PSYCHOTHERAPY; RHEUMATOID ARTHRITIS; SELF ESTEEM; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUALITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TURNER SYNDROME; VAGINAL DRYNESS; WHOLE BODY RADIATION; FEMALE; MENOPAUSE; PHYSIOLOGY; PSYCHOLOGY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

FEMALE; HUMANS; MENOPAUSE; MENOPAUSE, PREMATURE; PREVALENCE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUALITY;

EID: 77957035550     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05680.x     Document Type: Conference Paper

References (32)

1. Graziottin, A. 1998. The biological basis of female sexuality. Int. J. Clin. Pharmacol. 13(Suppl. 6): S15-S22.
2. Al-Azzawi, F., J. Bitzer, U. Brandenburg, et al. (FSD Education Team) 2010. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric. 13: 103-120.
3. Graziottin, A.&S.R. Leiblum 2005.Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J. Sex. Med. 2(Suppl. 3): 133-145.
4. Madanat, L.M.S., N.Malila, T. Dyba, et al. 2008. Probability of parenthood after early onset cancer: A population-based study Int. J. Cancer 123: 2891-2898.
5. Graziottin, A. & R. Basson. 2004. Sexual dysfunctions in women with premature menopause. Menopause 11: 766-777.
6. Fassnacht, W., A. Mempel, T. Strowitzki & P.H. Vogt. 2006. Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity Curr. Med. Chem. 13: 1397-1410.
7. Meskhi, A. & M.W. Seif. 2006. Premature ovarian failure. Curr. Opin. Obstet. Gynecol. 18: 418-426.
8. Anasti, J.N. 2006. Premature ovarian failure: an update. Fertil. Steril. 70: 1-15.
9. Rocca, W.A., J.H. Bower, D.M. Maraganore, et al. 2007 Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69: 1074-1083.
10. Graziottin, A., P.E. Koochaki, C. Rodenberg & L. Dennerstein. 2009. The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European Countries J. Sex. Med. 6: 2143-2153.
11. Rauck, A., D.M. Green, Y. Yasui, et al. 1999. Marriage in the survivors of childhood cancer: a preliminary study description from the Childhood Cancer Survivor Study Medical and Pediatric. Oncology 33: 60-63.
12. Shifren, J.L., J. Braunstein, J.A. Simon, et al. 2000. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.N. Engl. J. Med. 343: 682-688.
13. Buster, J.E., S.A. Kingsberg, O. Aguirre, et al. 2005. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet. Gynecol. 105(5 Pt 1): 944-952.
14. Simon, J., G. Braunstein, L. Nachtigall, et al. 2005. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder J. Clin. Endocrinol. Metab. 90: 5226-5233.
15. Davis, S.R., M.J. Van Der Mooren, R.H. van Lunsen, et al. 2006. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausalwomen: a randomized, placebo-controlled trial. Menopause 13: 387-396.
16. Luborsky, J.L., P. Meyer, M.F. Sowers, et al. 2003. Premature menopause in a multiethnic population study of the menopause transition. Hum. Reprod. 8: 199-206.
17. Puukko, L.M.R., E. Hirvonen, V. Aalberg, et al. 1997. Sexuality in young women surviving leukemia. Arch. Dis. Child. 76: 197-202.
18. Graziottin, A. 2007. Prevalence and evaluation of sexual health problems - HSDD in Europe. J. Sex. Med. 4(Suppl. 3); 211-219.
19. Schover, L.R. 1994. Sexuality and body image in younger women with breast cancer. J. Natl. Cancer Inst. Monogr. 16: 177-182.
20. Graziottin, A. & E. Castoldi. 2000. Sexuality and breast cancer: a review. In: The Management of the Menopause. The Millennium Review 2000. J. Studd, Ed.: 211-220. Parthenon Publishing. London, UK.
21. Graziottin, A. 2006. Breast cancer and its effects on womens self-image and sexual function. In:Womens Sexual Function and Dysfunction: Study, Diagnosis and Treatment. I. Goldstein, C.Meston, S. Davis & A. Traish, Eds.: 276-281. Taylor and Francis. London, UK.
22. Graziottin, A. 2005. The woman, patient afterWHI Maturitas 51: 29-37.
23. Bachmann, G., J.Bancroft, G.Braunstein, et al. 2002. FAI: the Princeton consensus statement on definition, classification and assessment. Fertil. Steril. 77: 660-665.
24. Alexander, J.L., L. Dennerstein, H. Burger & A. Graziottin 2006. Testosterone and libido in surgically and naturally menopausal women Womens Health 2: 459-477.
25. Graziottin, A. 2006. Sexual pain disorders (Dyspareunia and vaginismus). In: Standard Practice in Sexual Medicine. H. Porst&J. Buvat, Eds.: 342-350. Blackwell. Oxford,UK. ISSM (International Society of Sexual Medicine) Standard Committee Book. Available from www.alessandragraziottin.it )
26. Skouby, S.O. and the EMAS (European Menopause and Andropause Society)Writing Group 2004. Position statements on postmenopausal hormonal therapy. Maturitas 48: 19-25.
27. Burger, H. and the IMS (International Menopause Society) Writing group 2004. Practical recommendations for hormone replacement therapy in the peri and post menopause Climacteric 7: 1-7.
28. Oktay, K., E. Buyuk, O. Davis, et al. 2003. Fertility preservation in breast cancer patients: in vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen. Human Reprod. 18: 90-95.
29. Jonat, W., M. Kaufmann, W. Sauerbrei, et al. 2003. Goserelin vs. cyclophospamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients withnode-positive breast cancer: the Zoladex Early Breast Cancer Research Association Study. J. Clin. Oncol. 20: 4628-4635.
30. Somboonporn,W., S.Davis,M. Seif, et al. 2005. Testosterone for peri and postmenopausal women Cochrane Database Syst. Rev.: CD004509
31. Wierman, M.E., R. Basson, S.R. Davis, et al. 2006 Androgen therapy in women: an endocrine society clinical practice guideline J. Clin. Endocrinol. Metab. 91: 3697-3710.
32. Goldstein, I. & J.L. Alexander. 2005. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. Rev. J. Sex. Med. 2(Suppl. 3): 154-165.